Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...

Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...

But a new study has found that only one in 10 treatments for lower back pain are effective, with those that improve symptoms ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

Medication, physical therapy, steroid injections, and implanted devices may be helpful, but newer research has discovered ...

ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients ...

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity (NME), non-opioid, non-NSAID oral therapy ...

Summary: Viewing natural scenes can significantly reduce how people perceive pain, a new neuroimaging study has found.

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Latigo Biotherapeutics has secured $150m in a Series B financing round, which will be used to further the development of its ...